Project leader

 
Dr. Zoltan Asztalos
 

Institute presentation

Aktogen Hungary Ltd. is a wholly owned subsidiary of Aktogen Limited, Cambridge, UK. Aktogen aims to accelerate the discovery of drug targets and drugs for the treatment of human mental disorders. The company employs fruit fly, Drosophila m. genetic and pharmacological models of mental disorders for its discoveries. Aktogen has unique capabilities in developing automated fruit fly behaviour systems to effectively test complex behaviour that has relevance to mental disorders.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Until you give your consent, only those cookies necessary to maintain the website's functionality are active. When you choose "OK", so called third-party non-functional cookies (e.g. GDPR-conform Google Analytics) may also become active. Please be aware that the website's functionality may be restricted if you choose "DECLINE". You can revoke your choice at any time by clearing your browser cache/history and updating your selection. Please also view our privacy policy.
Ok Decline